-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Assumes West Pharmaceutical Servs at Outperform

Benzinga·06/02/2026 12:30:57
Listen to the news
Wolfe Research analyst Mike Polark assumes West Pharmaceutical Servs (NYSE:WST) with a Outperform rating.